Mettler-Toledo International Inc. — Q3 2022 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2022. The company supplies precision instruments and related services across laboratory, industrial, retail, and other markets. Financial statements are unaudited and prepared under U.S. GAAP.
Financial performance
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Net sales | $985.8 million | $952.0 million | $2,862.0 million | $2,680.7 million |
| Gross profit | $584.7 million | $555.8 million | $1,675.9 million | $1,564.4 million |
| Gross margin | 59.3% | 58.4% | 58.6% | 58.4% |
| Earnings before taxes | $275.9 million | $247.6 million | $745.6 million | $663.4 million |
| Net earnings | $220.6 million | $203.7 million | $606.7 million | $538.1 million |
| Diluted EPS | $9.76 | $8.71 | $26.58 | $22.86 |
- Sales increased 4% in U.S. dollars and 10% in local currency in Q3; nine-month sales rose 7% and 11%, respectively.
- Q3 net margin was 22.4%, versus 21.4%; nine-month net margin was 21.2%, versus 20.1%.
- For the first nine months, operating cash flow was $555.4 million, down from $667.7 million. Capital expenditures were $89.2 million, versus $69.8 million. Cash and cash equivalents ended at $122.1 million.
- Total debt was $1,978.9 million, including $153.6 million current and $1,825.3 million long-term debt. The company had $589.3 million of additional credit-facility availability. It reported compliance with debt covenants.
- Current assets were $1,315.9 million and current liabilities $1,164.9 million. Shareholders’ equity was negative $82.8 million at September 30, compared with positive $171.4 million at year-end 2021.
Material changes and operating trends
- Q3 growth was strongest in the Americas and Asia/Rest of World; sales by destination increased 11% and 7% in U.S. dollars, respectively, while Europe declined 12%. In local currency, Europe grew 1%.
- Laboratory and industrial categories grew; retail sales declined 2% in U.S. dollars in Q3. China’s sales grew 15% in local currency, while management cited lockdown uncertainty and weaker food-retail trends.
- Gross margin improved, which management attributed primarily to favorable price realization and higher volume, partly offset by higher material costs. SG&A as a share of sales fell to 23.7% from 25.3% in Q3.
- Interest expense increased to $14.5 million from $11.8 million in Q3 and to $38.6 million from $31.7 million for the nine-month period. Restructuring charges also increased, to $7.8 million from $2.7 million year to date.
- Operating cash flow fell year over year, primarily due to higher cash incentive payments and increased inventory. Inventory rose to $451.3 million from $414.5 million at December 31, 2021.
- The company spent $825.0 million on repurchases in the first nine months, compared with $727.5 million a year earlier. In November 2022, the board authorized an additional $2.5 billion for the repurchase program; approximately $1.2 billion remained available at September 30.
Outlook, risks, and unusual items
- The filing provides no specific quantitative earnings or revenue guidance. Management said operating results for the interim periods are not necessarily indicative of full-year results, and stated that current cash, operating cash flows, and available borrowing capacity should meet anticipated needs for the foreseeable future.
- Management highlighted COVID-19 and possible China lockdowns, supply-chain disruption and component shortages, higher materials and transportation costs, inflation, and the Ukraine conflict and related energy and currency uncertainty as risks to future sales and profitability. Shipments to Russia remained suspended; Russia and Ukraine together represented approximately 1% of 2021 sales.
- Foreign-exchange movements affected reported results. The company recorded net losses on foreign-currency forward contracts of $20.9 million in Q3 and $29.3 million year to date, primarily offset by underlying transaction effects. It estimated that a 1% weakening of the Chinese renminbi against the U.S. dollar would reduce annual pretax earnings by approximately $3.5–$3.7 million.
- The company issued $150 million of 15-year notes at 2.81% in March and another $150 million at 2.91% in September, with proceeds intended for refinancing and general corporate purposes. A $50 million note was due in December 2022.
- The company received $28.7 million of $35.8 million expected through 2023 under a U.S. Department of Defense funding agreement for domestic pipette-tip capacity and related automation. Management expected the Inflation Reduction Act’s financial impact to be immaterial.
- Management did not expect pending legal proceedings to have a material adverse effect. Disclosure controls were deemed effective; no material change in internal control was reported.
Important facts for investors to verify
- Whether sales and margin growth persist after currency effects, pricing benefits, and higher input costs are considered.
- Whether working-capital needs, particularly inventory, continue to constrain operating cash flow.
- How substantial repurchases and additional borrowing affect leverage, liquidity, and the company’s negative shareholders’ equity.
- The refinancing or repayment plan for debt maturities, including the December 2022 note, and the effect of interest rates and foreign-exchange movements on debt service.
- Whether China lockdowns, supply-chain challenges, inflation, and Ukraine-related energy and market risks materially alter demand or profitability.